Dupilumab for the Treatment of Atopic Dermatitis

Prescriber - United Kingdom
doi 10.1002/psb.1675
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Alopecia Areata After Dupilumab for Atopic Dermatitis

JAAD Case Reports
Dermatology
2018English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

535 New Regional Dermatoses During Dupilumab Therapy for Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Effectiveness of Dupilumab Treatment in 95 Patients With Atopic Dermatitis: Daily Practice Data

British Journal of Dermatology
DermatologyMedicine
2019English

Dupilumab-Induced Phenotype Switching From Atopic Dermatitis to Psoriasis

JAAD Case Reports
Dermatology
2020English

Real‐world Use of Dupilumab for 53 Patients With Atopic Dermatitis in Japan

Journal of Cutaneous Immunology and Allergy
2020English

Dupilumab in Atopic Dermatitis: Rationale, Latest Evidence and Place in Therapy

Therapeutic Advances in Chronic Disease
Medicine
2018English

673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Remission of Alopecia Universalis in a Patient With Atopic Dermatitis Treated With Dupilumab

JAAD Case Reports
Dermatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy